CBL-514 is a first-in-class small molecule drug designed to induce adipocyte apoptosis and lipolysis. The Food and Drug Administration (FDA) has granted Fast Track designation to CBL-514 for the ...
NEW TAIPEI CITY, Jan. 8, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the United States Food and Drug Administration (U.S. FDA) has accepted the CBL-514 Investigational New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results